title: JAK inhibition in myelofibrosis.
authors.forename: Eduardo
authors.initials: E
authors.lastname: Arellano-Rodrigo
authors.forename: Alberto
authors.initials: A
authors.lastname: Alvarez-Larrán
mesh_terms: D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D053613:Janus Kinase 1 / Q000037:antagonists & inhibitors*; D053614:Janus Kinase 2 / Q000037:antagonists & inhibitors*; D009154:Mutation; D009570:Nitriles; D010166:Palliative Care; D055728:Primary Myelofibrosis / Q000150:complications / Q000188:drug therapy*; D011720:Pyrazoles / Q000009:adverse effects / Q000627:therapeutic use*; D011743:Pyrimidines; D053628:Receptors, Thrombopoietin / Q000235:genetics; D013927:Thrombosis / Q000209:etiology*
chemical_list: D009570:Nitriles; D011720:Pyrazoles; D011743:Pyrimidines; D053628:Receptors, Thrombopoietin; C540383:ruxolitinib; D053613:Janus Kinase 1; D053614:Janus Kinase 2; D006918:Hydroxyurea